ANEXIGEN

Anexigen is a developer of novel methods and compositions designed to combat existing and burgeoning antimicrobial threats. The company's platform has the potential to identify novel antibacterial agents with activity against drug-resistant bacteria of biomedical interest and enables functional screening of DNA-encoded peptide-based libraries directly on any Gram-negative pathogen to identify novel antibiotic chemical scaffolds, enabling clinicians and patients to defeat drug-resistant pathogens with the power of Surface Localized Antimicrobial Display (SLAY) platform.